Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, AVO

/R E P E A T -- Media Advisory - Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!/


As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases will march on Parliament Hill to ask for the same support in the 'Fight for Our Lives'

OTTAWA, March 9, 2020 /CNW/ - THE ISSUE: The federal government's draconian new patented drug pricing rules to be implemented by the Patented Medicine Prices Review Board (PMPRB) prevent life-saving treatments from coming to Canada. It's already happening ? remarkable new treatments for cystic fibrosis and sickle cell disease are now available elsewhere but haven't even been filed for approval here.

THE EVENT: The Canadian Organization for Rare Disorders (CORD) is leading a contingent of Canadian patients with rare and common diseases to Parliament Hill to "Fight for Our Lives" and to deliver one common message to their Members of Parliament: "Stop the PMPRB!" 

WHEN: Tuesday, March 10, 2020, at 12 pm

WHERE: Centennial Flame, Parliament Hill, Ottawa

Leaders of CORD and representatives of Canadians with cystic fibrosis and sickle cell disease are available to explain the crisis facing Canadian patients.

"The federal drug price controls are a death sentence for many patients." ? Chris McLeod, Chair of the Canadian Cystic Fibrosis Treatment Society and a CF patient.

"For decades, there have been no effective treatments for sickle cell disease. We now have a revolutionary new drug that can prevent the root cause of the disease, but it won't be made available to Canadians any time soon." ? Biba Tinga, President and Executive Director of the Sickle Cell Disease Association of Canada.

SOURCE CANADIAN ORGANIZATION FOR RARE DISORDERS (CORD)


These press releases may also interest you

at 05:10
Neurology Devices: Global Markets is basically a detailed study or report about the worldwide market for medical tools used in treating neurological conditions. These devices could be anything from equipment that helps stimulate the nervous system to...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...



News published on and distributed by: